Holen Sie sich die Stockscreener-App
9.94
1.12%
0.11
Handel nachbörslich:
10.01
0.07
+0.70%
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law - Business Wire
Advantage Alpha Capital Partners LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. (NASDAQ:ADMA) Investors to Contact the Firm Regarding Ongoing Investigation - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Shareholders to Reach Out - ACCESS Newswire
ADMA Technical Analysis & Stock Price Forecast - Intellectia AI
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - The Globe and Mail
ADMA Investor Announcement: ADMA Biologics Investigated - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics Under Investigation for Securities Violations - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA) - Seeking Alpha
Aberdeen Group Reduces ADMA Biologics Stake - National Today
ADMA Biologics gains after refuting short seller claims - MSN
ADMA Biologics Inc $ADMA Stock Holdings Lessened by Aberdeen Group plc - MarketBeat
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc. - ACCESS Newswire
ADMA stock downgraded by Cantor as ‘channel stuffing’ claims shake investor confidence - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over - GlobeNewswire
Shareholder News: ADMA Biologics (NASDAQ:ADMA) Drops 29% - GlobeNewswire
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics slams short seller claims, highlights strong demand - MSN
ADMA Biologics extends selloff as Cantor downgrades after short report - MSN
ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ADMA | Press Release - Stockhouse
ADMA SEC FilingsAdma Biologics 10-K, 10-Q, 8-K Forms - Stock Titan
ADMA PE Ratio & Valuation, Is ADMA Overvalued - intellectia.ai
US High Growth Tech Stocks To Watch For Potential Expansion - Sahm
Stock Drop Alert: ADMA Biologics ($ADMA) Stock Plummets 29% after Channel Stuffing Claims DisclosedInvestors Notified of Securities Fraud Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Investors to Connect - ACCESS Newswire
ADMA Biologics Under Investigation for Securities Fraud Allegations - Intellectia AI
ADMA (ADMA) COO reports 20,362-share RSU tax withholding, holds 446,238 shares - Stock Titan
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating ADMA Biologics, Inc. (ADMA) And Encourages Investors to Connect | NDAQ:ADMA | Press Release - Stockhouse
ADMA Biologics Investigated for Securities Fraud After Plunge - National Today
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Short seller report alleges ADMA Biologics financial misrepresentation - MSN
Trading the Move, Not the Narrative: (ADMA) Edition - Stock Traders Daily
ADMA Investor Alert: ADMA Biologics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Revenue Headwinds: Levi & Korsinsky - Sahm
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inqui - The National Law Review
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation – ADMA - eagletribune.com
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026? - Zacks Investment Research
ADMA Biologics Under Investigation for Securities Fraud - Intellectia AI
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Investors to Reach Out - ACCESS Newswire
Investor Notice: ADMA Biologics ($ADMA) Stock Dropped 29% After Culper Research Report AnnouncementInvestigation Pending - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ADMA ... - Bluefield Daily Telegraph
ADMA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential ... - Bluefield Daily Telegraph
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
ADMA Biologics Investigated for Securities Fraud After Stock Drop - National Today
ADMA Biologics Investigated for Securities Fraud After Plummeting Stock - National Today
ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop - PR Newswire
Adma Biologics (ADMA) Shares Fall as Overall Market Rises: Key Insights for Investors - Bitget
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Stockholders to Reach Out - ACCESS Newswire
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating - PR Newswire
2026-03-30 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Stockholders to Reach Out | NDAQ:ADMA | Press Release - Stockhouse
1.57%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):